Skip to main content
Top
Published in: Journal of Translational Medicine 1/2012

Open Access 01-12-2012 | Research

Matrix Metalloproteinase-dependent turnover of cartilage, synovial membrane, and connective tissue is elevated in rats with collagen induced arthritis

Authors: Anne Sofie Siebuhr, Jianxia Wang, Morten Karsdal, Anne-C Bay-Jensen, Jin Y, Zheng Q

Published in: Journal of Translational Medicine | Issue 1/2012

Login to get access

Abstract

Background

Rheumatoid arthritis is a disease affecting the extracellular matrix of especially synovial joints. The thickness of the synovial membrane increases and surrounding tissue degrades, leading to altered collagen balance in the tissues. In this study, we investigated the altered tissue balance of cartilage, synovial membrane, and connective tissue in collagen induced arthritis (CIA) in rats.

Methods

Six newly developed ELISAs quantifying MMP-derived collagen degradation (C1M, C2M, and C3M) and formation (P1NP, P2NP, and P3NP) was used to detect cartilage turnover in rats with CIA. Moreover, CTX-II was used to detect alternative type II collagen degradation and as control of the model. 10 Lewis rats were injected with porcrine type II collagen twice with a 7 day interval and 10 rats was injected with 0.05 M acetic acid as control. The experiment ran for 26 days.

Results

A significant increase in the degradation of type I, II, and III collagen (C1M, C2M, and C3M, respectively) was detected on day 22 (P = 0.0068, P = 0.0068, P < 0.0001, respectively), whereas no significant difference in formation (P1NP, P2NP, and P3NP) was detected at any time point (P=0.22, P=0.53, P=0.53, respectively). The CTX-II level increased strongly from disease onset and onwards.

Conclusion

A nearly total separation between diseased and control animals was detected with C3M, making it a good diagnostic marker. The balance of type I, II, and III collagen was significantly altered with CIA in rats, with favour of degradation of the investigated collagens. This indicates unbalanced turnover of the surrounding tissues of the synovial joints, leading to increased pain and degeneration of the synovial joints.
Appendix
Available only for authorised users
Literature
1.
go back to reference Buch M, Emery P: The aetiology and pathogenesis of Rheumatoid arthritis. Hospital Parmacist. 2002, Ref Type: In Press Buch M, Emery P: The aetiology and pathogenesis of Rheumatoid arthritis. Hospital Parmacist. 2002, Ref Type: In Press
2.
3.
go back to reference Macgregor AJ: Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum. 2000, 43: 30-37. 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B.CrossRefPubMed Macgregor AJ: Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum. 2000, 43: 30-37. 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B.CrossRefPubMed
4.
go back to reference Deighton CM, Wentzel J, Cavanagh G, Roberts DF, Walker DJ: Contribution of inherited factors to rheumatoid arthritis. Ann Rheum Dis. 1992, 51: 182-185. 10.1136/ard.51.2.182.CrossRefPubMedPubMedCentral Deighton CM, Wentzel J, Cavanagh G, Roberts DF, Walker DJ: Contribution of inherited factors to rheumatoid arthritis. Ann Rheum Dis. 1992, 51: 182-185. 10.1136/ard.51.2.182.CrossRefPubMedPubMedCentral
5.
go back to reference Rousseau JC: Patients with rheumatoid arthritis have an altered circulatory aggrecan profile. BMC Musculoskelet Disord. 2008, 9: 74-10.1186/1471-2474-9-74.CrossRefPubMedPubMedCentral Rousseau JC: Patients with rheumatoid arthritis have an altered circulatory aggrecan profile. BMC Musculoskelet Disord. 2008, 9: 74-10.1186/1471-2474-9-74.CrossRefPubMedPubMedCentral
6.
go back to reference Keyszer G: Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers. J Rheumatol. 1999, 26 (2): 251-258.PubMed Keyszer G: Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers. J Rheumatol. 1999, 26 (2): 251-258.PubMed
7.
go back to reference Mamehara A: Serum matrix metalloproteinase-3 as predictor of joint destruction in rheumatoid arthritis, treated with non-biological disease modifying anti-rheumatic drugs. Kobe J Med Sci. 2010, 56: E98-E107.PubMed Mamehara A: Serum matrix metalloproteinase-3 as predictor of joint destruction in rheumatoid arthritis, treated with non-biological disease modifying anti-rheumatic drugs. Kobe J Med Sci. 2010, 56: E98-E107.PubMed
9.
go back to reference Eyre DR, Muir H: Type III collagen: A major constituent of rheumatoid and normal human synovial membrane. Connect Tissue Res. 1975, 4: 11-16. 10.3109/03008207509152192.CrossRefPubMed Eyre DR, Muir H: Type III collagen: A major constituent of rheumatoid and normal human synovial membrane. Connect Tissue Res. 1975, 4: 11-16. 10.3109/03008207509152192.CrossRefPubMed
10.
go back to reference Lovell CR, Nicholls AC, Jayson MI, Bailey AJ: Changes in the collagen of synovial membrane in rheumatoid arthritis and effect of D-penicillamine. Clin Sci Mol Med. 1978, 55: 31-40.PubMed Lovell CR, Nicholls AC, Jayson MI, Bailey AJ: Changes in the collagen of synovial membrane in rheumatoid arthritis and effect of D-penicillamine. Clin Sci Mol Med. 1978, 55: 31-40.PubMed
11.
go back to reference Weiss JB: Occurrence of type III collagen in inflamed synovial membranes: a comparison between non rheumatoid, rheumatoid, and normal synovial collagens. Biochem Biophys Res Commun. 1975, 65: 907-912. 10.1016/S0006-291X(75)80471-2.CrossRefPubMed Weiss JB: Occurrence of type III collagen in inflamed synovial membranes: a comparison between non rheumatoid, rheumatoid, and normal synovial collagens. Biochem Biophys Res Commun. 1975, 65: 907-912. 10.1016/S0006-291X(75)80471-2.CrossRefPubMed
12.
go back to reference Konttinen YT: Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis. 1999, 58: 691-697. 10.1136/ard.58.11.691.CrossRefPubMedPubMedCentral Konttinen YT: Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis. 1999, 58: 691-697. 10.1136/ard.58.11.691.CrossRefPubMedPubMedCentral
13.
go back to reference Kim KS: Expression levels and association of gelatinases MMP-2 and MMP-9 and collagenases MMP-1 and MMP-13 with VEGF in synovial fluid of patients with arthritis. Rheumatol Int. 2011, 31: 543-547. 10.1007/s00296-010-1592-1.CrossRefPubMed Kim KS: Expression levels and association of gelatinases MMP-2 and MMP-9 and collagenases MMP-1 and MMP-13 with VEGF in synovial fluid of patients with arthritis. Rheumatol Int. 2011, 31: 543-547. 10.1007/s00296-010-1592-1.CrossRefPubMed
14.
go back to reference Pap T: Differential expression pattern of membrane-type matrix metalloproteinases in rheumatoid arthritis. Arthritis Rheum. 2000, 43: 1226-1232. 10.1002/1529-0131(200006)43:6<1226::AID-ANR5>3.0.CO;2-4.CrossRefPubMed Pap T: Differential expression pattern of membrane-type matrix metalloproteinases in rheumatoid arthritis. Arthritis Rheum. 2000, 43: 1226-1232. 10.1002/1529-0131(200006)43:6<1226::AID-ANR5>3.0.CO;2-4.CrossRefPubMed
15.
go back to reference Lee EG: Ethyl acetate fraction from Cudrania tricuspidata inhibits IL-1beta-induced rheumatoid synovial fibroblast proliferation and MMPs, COX-2 and PGE2 production. Biol Res. 2010, 43: 225-231.CrossRefPubMed Lee EG: Ethyl acetate fraction from Cudrania tricuspidata inhibits IL-1beta-induced rheumatoid synovial fibroblast proliferation and MMPs, COX-2 and PGE2 production. Biol Res. 2010, 43: 225-231.CrossRefPubMed
16.
go back to reference Bonde M: Measurement of bone degradation products in serum using antibodies reactive with an isomerized form of an 8 amino acid sequence of the C-telopeptide of type I collagen. J Bone Miner Res. 1997, 12: 1028-1034. 10.1359/jbmr.1997.12.7.1028.CrossRefPubMed Bonde M: Measurement of bone degradation products in serum using antibodies reactive with an isomerized form of an 8 amino acid sequence of the C-telopeptide of type I collagen. J Bone Miner Res. 1997, 12: 1028-1034. 10.1359/jbmr.1997.12.7.1028.CrossRefPubMed
17.
go back to reference Rousseau JC: Serum levels of type IIA procollagen amino terminal propeptide (PIIANP) are decreased in patients with knee osteoarthritis and rheumatoid arthritis. Osteoarthritis Cartilage. 2004, 12 (6): 440-7. 10.1016/j.joca.2004.02.004.CrossRefPubMed Rousseau JC: Serum levels of type IIA procollagen amino terminal propeptide (PIIANP) are decreased in patients with knee osteoarthritis and rheumatoid arthritis. Osteoarthritis Cartilage. 2004, 12 (6): 440-7. 10.1016/j.joca.2004.02.004.CrossRefPubMed
18.
go back to reference Smith RK, Heinegard D: Cartilage oligomeric matrix protein (COMP) levels in digital sheath synovial fluid and serum with tendon injury. Equine Vet J. 2000, 32: 52-58.CrossRefPubMed Smith RK, Heinegard D: Cartilage oligomeric matrix protein (COMP) levels in digital sheath synovial fluid and serum with tendon injury. Equine Vet J. 2000, 32: 52-58.CrossRefPubMed
19.
go back to reference Melkko J, Niemi S, Risteli L, Risteli J: Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clin Chem. 1990, 36: 1328-1332.PubMed Melkko J, Niemi S, Risteli L, Risteli J: Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clin Chem. 1990, 36: 1328-1332.PubMed
20.
go back to reference Leeming D: A novel marker for assessment of liver matrix remodeling: an enzyme-linked immunosorbent assay (ELISA) detecting a MMP generated type I collagen neo-epitope (C1M). Biomarkers. 2011, 16: 616-628. 10.3109/1354750X.2011.620628.CrossRefPubMed Leeming D: A novel marker for assessment of liver matrix remodeling: an enzyme-linked immunosorbent assay (ELISA) detecting a MMP generated type I collagen neo-epitope (C1M). Biomarkers. 2011, 16: 616-628. 10.3109/1354750X.2011.620628.CrossRefPubMed
21.
go back to reference Bay-Jensen AC: Enzyme-linked immunosorbent assay (ELISAs) for metalloproteinase derived type II collagen neoepitope, CIIM–increased serum CIIM in subjects with severe radiographic osteoarthritis. Clin Biochem. 2011, 44: 423-429. 10.1016/j.clinbiochem.2011.01.001.CrossRefPubMed Bay-Jensen AC: Enzyme-linked immunosorbent assay (ELISAs) for metalloproteinase derived type II collagen neoepitope, CIIM–increased serum CIIM in subjects with severe radiographic osteoarthritis. Clin Biochem. 2011, 44: 423-429. 10.1016/j.clinbiochem.2011.01.001.CrossRefPubMed
22.
go back to reference Barascuk N: A novel assay for extracellular matrix remodeling associated with liver fibrosis: An enzyme-linked immunosorbent assay (ELISA) for a MMP-9 proteolytically revealed neo-epitope of type III collagen. Clin Biochem. 2010, 43: 899-904. 10.1016/j.clinbiochem.2010.03.012.CrossRefPubMed Barascuk N: A novel assay for extracellular matrix remodeling associated with liver fibrosis: An enzyme-linked immunosorbent assay (ELISA) for a MMP-9 proteolytically revealed neo-epitope of type III collagen. Clin Biochem. 2010, 43: 899-904. 10.1016/j.clinbiochem.2010.03.012.CrossRefPubMed
23.
go back to reference Leeming DJ: Enzyme-linked immunosorbent serum assays (ELISAs) for rat and human N-terminal pro-peptide of collagen type I (PINP)–assessment of corresponding epitopes. Clin Biochem. 2010, 43: 1249-1256. 10.1016/j.clinbiochem.2010.07.025.CrossRefPubMed Leeming DJ: Enzyme-linked immunosorbent serum assays (ELISAs) for rat and human N-terminal pro-peptide of collagen type I (PINP)–assessment of corresponding epitopes. Clin Biochem. 2010, 43: 1249-1256. 10.1016/j.clinbiochem.2010.07.025.CrossRefPubMed
24.
go back to reference Vassiliadis E: Measurement of CO3-610, a Potential Liver Biomarker Derived from Matrix Metalloproteinase-9 Degradation of Collagen Type III, in a Rat Model of Reversible Carbon-Tetrachloride-Induced Fibrosis. Biomark Insights. 2011, 6: 49-58.CrossRefPubMedPubMedCentral Vassiliadis E: Measurement of CO3-610, a Potential Liver Biomarker Derived from Matrix Metalloproteinase-9 Degradation of Collagen Type III, in a Rat Model of Reversible Carbon-Tetrachloride-Induced Fibrosis. Biomark Insights. 2011, 6: 49-58.CrossRefPubMedPubMedCentral
25.
go back to reference Veidal SS: Matrix metalloproteinase-9-mediated type III collagen degradation as a novel serological biochemical marker for liver fibrogenesis. Liver Int. 2010, 30: 1293-1304. 10.1111/j.1478-3231.2010.02309.x.CrossRefPubMed Veidal SS: Matrix metalloproteinase-9-mediated type III collagen degradation as a novel serological biochemical marker for liver fibrogenesis. Liver Int. 2010, 30: 1293-1304. 10.1111/j.1478-3231.2010.02309.x.CrossRefPubMed
26.
go back to reference Vassiliadis E: Measurement of matrix metalloproteinase 9-mediated collagen type III degradation fragment as a marker of skin fibrosis. BMC Dermatol. 2011, 11: 6-10.1186/1471-5945-11-6.CrossRefPubMedPubMedCentral Vassiliadis E: Measurement of matrix metalloproteinase 9-mediated collagen type III degradation fragment as a marker of skin fibrosis. BMC Dermatol. 2011, 11: 6-10.1186/1471-5945-11-6.CrossRefPubMedPubMedCentral
27.
go back to reference Lin DY, Chu CM, Sheen IS, Liaw YF: Serum carboxy terminal propeptide of type I procollagen to amino terminal propeptide of type III procollagen ratio is a better indicator than each single propeptide and 7S domain type IV collagen for progressive fibrogenesis in chronic viral liver diseases. Dig Dis Sci. 1995, 40: 21-27. 10.1007/BF02063936.CrossRefPubMed Lin DY, Chu CM, Sheen IS, Liaw YF: Serum carboxy terminal propeptide of type I procollagen to amino terminal propeptide of type III procollagen ratio is a better indicator than each single propeptide and 7S domain type IV collagen for progressive fibrogenesis in chronic viral liver diseases. Dig Dis Sci. 1995, 40: 21-27. 10.1007/BF02063936.CrossRefPubMed
28.
go back to reference Ulrich D, Noah EM, Burchardt ER, Atkins D, Pallua N: Serum concentration of amino-terminal propeptide of type III procollagen (PIIINP) as a prognostic marker for skin fibrosis after scar correction in burned patients. Burns. 2002, 28: 766-771. 10.1016/S0305-4179(02)00193-6.CrossRefPubMed Ulrich D, Noah EM, Burchardt ER, Atkins D, Pallua N: Serum concentration of amino-terminal propeptide of type III procollagen (PIIINP) as a prognostic marker for skin fibrosis after scar correction in burned patients. Burns. 2002, 28: 766-771. 10.1016/S0305-4179(02)00193-6.CrossRefPubMed
29.
go back to reference Bay-Jensen AC: Ankylosing spondylitis is characterized by an increased turnover of several different metalloproteinase-derived collagen species: a cross-sectional study. Rheumatol Int. 2011 Bay-Jensen AC: Ankylosing spondylitis is characterized by an increased turnover of several different metalloproteinase-derived collagen species: a cross-sectional study. Rheumatol Int. 2011
30.
go back to reference Nielsen RH, Christiansen C, Stolina M, Karsdal MA: Oestrogen exhibits type II collagen protective effects and attenuates collagen-induced arthritis in rats. Clin Exp Immunol. 2008, 152: 21-27. 10.1111/j.1365-2249.2008.03594.x.CrossRefPubMedPubMedCentral Nielsen RH, Christiansen C, Stolina M, Karsdal MA: Oestrogen exhibits type II collagen protective effects and attenuates collagen-induced arthritis in rats. Clin Exp Immunol. 2008, 152: 21-27. 10.1111/j.1365-2249.2008.03594.x.CrossRefPubMedPubMedCentral
31.
go back to reference Bolon B: Rodent preclinical models for developing novel antiarthritic molecules: comparative biology and preferred methods for evaluating efficacy. J Biomed Biotechnol. 2011, 2011: 569068-CrossRefPubMedPubMedCentral Bolon B: Rodent preclinical models for developing novel antiarthritic molecules: comparative biology and preferred methods for evaluating efficacy. J Biomed Biotechnol. 2011, 2011: 569068-CrossRefPubMedPubMedCentral
32.
go back to reference Fereidoni M, Ahmadiani A, Semnanian S, Javan M: An accurate and simple method for measurement of paw edema. J Pharmacol Toxicol Methods. 2000, 43: 11-14. 10.1016/S1056-8719(00)00089-7.CrossRefPubMed Fereidoni M, Ahmadiani A, Semnanian S, Javan M: An accurate and simple method for measurement of paw edema. J Pharmacol Toxicol Methods. 2000, 43: 11-14. 10.1016/S1056-8719(00)00089-7.CrossRefPubMed
33.
go back to reference Immunodiagnostic Systems Inc.: Method. 2012, Ref Type: Electronic Citation Immunodiagnostic Systems Inc.: Method. 2012, Ref Type: Electronic Citation
34.
go back to reference Trojanowska M, LeRoy EC, Eckes B, Krieg T: Pathogenesis of fibrosis: type 1 collagen and the skin. J Mol Med (Berl). 1998, 76: 266-274. 10.1007/s001090050216.CrossRef Trojanowska M, LeRoy EC, Eckes B, Krieg T: Pathogenesis of fibrosis: type 1 collagen and the skin. J Mol Med (Berl). 1998, 76: 266-274. 10.1007/s001090050216.CrossRef
35.
go back to reference Jokinen J: Integrin-mediated cell adhesion to type I collagen fibrils. J Biol Chem. 2004, 279: 31956-31963. 10.1074/jbc.M401409200.CrossRefPubMed Jokinen J: Integrin-mediated cell adhesion to type I collagen fibrils. J Biol Chem. 2004, 279: 31956-31963. 10.1074/jbc.M401409200.CrossRefPubMed
36.
go back to reference Dzamba BJ, Wu H, Jaenisch R, Peters DM: Fibronectin binding site in type I collagen regulates fibronectin fibril formation. J Cell Biol. 1993, 121: 1165-1172. 10.1083/jcb.121.5.1165.CrossRefPubMed Dzamba BJ, Wu H, Jaenisch R, Peters DM: Fibronectin binding site in type I collagen regulates fibronectin fibril formation. J Cell Biol. 1993, 121: 1165-1172. 10.1083/jcb.121.5.1165.CrossRefPubMed
37.
go back to reference Christensen AF: Uncoupling of collagen II metabolism in newly diagnosed, untreated rheumatoid arthritis is linked to inflammation and antibodies against cyclic citrullinated peptides. J Rheumatol. 2010, 37: 1113-1120. 10.3899/jrheum.091265.CrossRefPubMed Christensen AF: Uncoupling of collagen II metabolism in newly diagnosed, untreated rheumatoid arthritis is linked to inflammation and antibodies against cyclic citrullinated peptides. J Rheumatol. 2010, 37: 1113-1120. 10.3899/jrheum.091265.CrossRefPubMed
38.
go back to reference Karsdal MA: Biochemical markers of ongoing joint damage in rheumatoid arthritis–current and future applications, limitations and opportunities. Arthritis Res Ther. 2011, 13: 215-10.1186/ar3280.CrossRefPubMedPubMedCentral Karsdal MA: Biochemical markers of ongoing joint damage in rheumatoid arthritis–current and future applications, limitations and opportunities. Arthritis Res Ther. 2011, 13: 215-10.1186/ar3280.CrossRefPubMedPubMedCentral
39.
go back to reference Landewe R: Markers for type II collagen breakdown predict the effect of disease-modifying treatment on long-term radiographic progression in patients with rheumatoid arthritis. Arthritis Rheum. 2004, 50: 1390-1399. 10.1002/art.20222.CrossRefPubMed Landewe R: Markers for type II collagen breakdown predict the effect of disease-modifying treatment on long-term radiographic progression in patients with rheumatoid arthritis. Arthritis Rheum. 2004, 50: 1390-1399. 10.1002/art.20222.CrossRefPubMed
40.
go back to reference Bay-Jensen AC: Biochemical markers of type II collagen breakdown and synthesis are positioned at specific sites in human osteoarthritic knee cartilage. Osteoarthritis Cartilage. 2008, 16: 615-623. 10.1016/j.joca.2007.09.006.CrossRefPubMed Bay-Jensen AC: Biochemical markers of type II collagen breakdown and synthesis are positioned at specific sites in human osteoarthritic knee cartilage. Osteoarthritis Cartilage. 2008, 16: 615-623. 10.1016/j.joca.2007.09.006.CrossRefPubMed
41.
go back to reference Charni-Ben TN: The type II collagen fragments Helix-II and CTX-II reveal different enzymatic pathways of human cartilage collagen degradation. Osteoarthritis Cartilage. 2008, 16: 1183-1191. 10.1016/j.joca.2008.02.008.CrossRef Charni-Ben TN: The type II collagen fragments Helix-II and CTX-II reveal different enzymatic pathways of human cartilage collagen degradation. Osteoarthritis Cartilage. 2008, 16: 1183-1191. 10.1016/j.joca.2008.02.008.CrossRef
42.
go back to reference Jensen LT: The aminoterminal propeptide of type III procollagen. Studies on physiology and pathophysiology. Dan Med Bull. 1997, 44: 70-78.PubMed Jensen LT: The aminoterminal propeptide of type III procollagen. Studies on physiology and pathophysiology. Dan Med Bull. 1997, 44: 70-78.PubMed
43.
go back to reference Myllyla R, Becvar R, Adam M, Kivirikko KI: Markers of collagen metabolism in sera of patients with various rheumatic diseases. Clin Chim Acta. 1989, 183: 243-252. 10.1016/0009-8981(89)90358-6.CrossRefPubMed Myllyla R, Becvar R, Adam M, Kivirikko KI: Markers of collagen metabolism in sera of patients with various rheumatic diseases. Clin Chim Acta. 1989, 183: 243-252. 10.1016/0009-8981(89)90358-6.CrossRefPubMed
44.
go back to reference Hakala M: Application of markers of collagen metabolism in serum and synovial fluid for assessment of disease process in patients with rheumatoid arthritis. Ann Rheum Dis. 1995, 54: 886-890. 10.1136/ard.54.11.886.CrossRefPubMedPubMedCentral Hakala M: Application of markers of collagen metabolism in serum and synovial fluid for assessment of disease process in patients with rheumatoid arthritis. Ann Rheum Dis. 1995, 54: 886-890. 10.1136/ard.54.11.886.CrossRefPubMedPubMedCentral
45.
go back to reference Fueldner C: Identification and evaluation of novel synovial tissue biomarkers in rheumatoid arthritis by laser scanning cytometry. Arthritis Res Ther. 2012, 14: R8-10.1186/ar3682.CrossRefPubMedPubMedCentral Fueldner C: Identification and evaluation of novel synovial tissue biomarkers in rheumatoid arthritis by laser scanning cytometry. Arthritis Res Ther. 2012, 14: R8-10.1186/ar3682.CrossRefPubMedPubMedCentral
46.
go back to reference Syversen SW: Biomarkers in early rheumatoid arthritis: longitudinal associations with inflammation and joint destruction measured by magnetic resonance imaging and conventional radiographs. Ann Rheum Dis. 2010, 69: 845-850. 10.1136/ard.2009.122325.CrossRefPubMed Syversen SW: Biomarkers in early rheumatoid arthritis: longitudinal associations with inflammation and joint destruction measured by magnetic resonance imaging and conventional radiographs. Ann Rheum Dis. 2010, 69: 845-850. 10.1136/ard.2009.122325.CrossRefPubMed
Metadata
Title
Matrix Metalloproteinase-dependent turnover of cartilage, synovial membrane, and connective tissue is elevated in rats with collagen induced arthritis
Authors
Anne Sofie Siebuhr
Jianxia Wang
Morten Karsdal
Anne-C Bay-Jensen
Jin Y
Zheng Q
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2012
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/1479-5876-10-195

Other articles of this Issue 1/2012

Journal of Translational Medicine 1/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.